Huixian X. Miao
No. 300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Overcoming Ferroptosis-Induced Exhaustion of NK Cells through Inhibition of the ATF3-Mediated Integrated Stress Response in Ovarian Cancer.
Journal: International journal of biological sciences
Published: February 21, 2025
YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification.
Journal: Cancer letters
Published: March 24, 2024
CircRAD23B promotes proliferation and carboplatin resistance in ovarian cancer cell lines and organoids.
Journal: Cancer cell international
Published: November 04, 2023
Impact of surgical approach on progress of disease by type of histology in stage IA endometrial cancer: a matched-pair analysis.
Journal: BMC surgery
Published: August 24, 2023
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism.
Journal: Cell death and differentiation
Published: August 11, 2023
Preoperative hysteroscopy shortened progression-free survival in advanced FIGO stage in endometrial cancer: Ten year analysis.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: August 03, 2023
Establishment and preliminary application of organoids in ovarian cancer
Journal: Zhonghua fu chan ke za zhi
Published: February 13, 2023
Spin Manipulation in a Metal-Organic Layer through Mechanical Exfoliation for Highly Selective CO2 Photoreduction.
Journal: Angewandte Chemie (International ed. in English)
Published: February 08, 2023
Multicomponent Anti-Kasha's Rule Emission from Nanotubular Metal-Organic Frameworks for Selective Detection of Small Molecules.
Journal: Inorganic chemistry
Published: February 06, 2023
High-temperature negative thermal quenching phosphors from molecular-based materials.
Journal: Chemical communications (Cambridge, England)
Published: January 11, 2023
Bractoppin, a BRCA1 carboxy-terminal domain (BRCT) inhibitor, suppresses tumor progression in ovarian borderline tumor organoids.
Journal: Biochemical and biophysical research communications
Published: November 14, 2022
Last Updated: 09/26/2026